BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17089036)

  • 1. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
    Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
    Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
    Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
    Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter CpG methylation of tumor suppressor genes in colorectal cancer and its relationship to clinical features.
    Lin SY; Yeh KT; Chen WT; Chen HC; Chen ST; Chiou HY; Chang JG
    Oncol Rep; 2004 Feb; 11(2):341-8. PubMed ID: 14719065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
    Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
    Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
    Murao K; Kubo Y; Ohtani N; Hara E; Arase S
    Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation in promoter region of retinoic acid receptor-beta gene and immunohistochemical findings on retinoic acid receptors in carcinogenesis of endometrium.
    Li R; Saito T; Tanaka R; Satohisa S; Adachi K; Horie M; Akashi Y; Kudo R
    Cancer Lett; 2005 Feb; 219(1):33-40. PubMed ID: 15694662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma.
    Ksiaa F; Ziadi S; Amara K; Korbi S; Trimeche M
    Clin Chim Acta; 2009 Jun; 404(2):128-33. PubMed ID: 19336228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of adenomatous polyposis coli in endometrial cancer occurs more frequently in tumors with microsatellite instability phenotype.
    Zysman M; Saka A; Millar A; Knight J; Chapman W; Bapat B
    Cancer Res; 2002 Jul; 62(13):3663-6. PubMed ID: 12097272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases.
    Hori M; Iwasaki M; Shimazaki J; Inagawa S; Itabashi M
    Gynecol Oncol; 2000 Jan; 76(1):89-96. PubMed ID: 10620447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
    Saito T; Nishimura M; Yamasaki H; Kudo R
    Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer.
    Hsu HS; Wen CK; Tang YA; Lin RK; Li WY; Hsu WH; Wang YC
    Clin Cancer Res; 2005 Aug; 11(15):5410-6. PubMed ID: 16061855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
    Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
    Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation in promoter-associated CpG islands of multiple genes in therapy-related leukemia.
    Uehara E; Takeuchi S; Tasaka T; Matsuhashi Y; Yang Y; Fujita M; Tamura T; Nagai M; Koeffler HP
    Int J Oncol; 2003 Sep; 23(3):693-6. PubMed ID: 12888905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS; Kim MJ; Lee JY; Kim YZ; Kim EJ; Park JY
    Cancer; 2007 Dec; 110(12):2785-92. PubMed ID: 17960794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation.
    Suehiro Y; Okada T; Okada T; Anno K; Okayama N; Ueno K; Hiura M; Nakamura M; Kondo T; Oga A; Kawauchi S; Hirabayashi K; Numa F; Ito T; Saito T; Sasaki K; Hinoda Y
    Clin Cancer Res; 2008 Jun; 14(11):3354-61. PubMed ID: 18519763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation of cancer-related genes in gastric carcinoma.
    Poplawski T; Tomaszewska K; Galicki M; Morawiec Z; Blasiak J
    Exp Oncol; 2008 Jun; 30(2):112-6. PubMed ID: 18566573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.